Schroder Investment Management Group
MBX

Schroder Investment Management Group’s MBX Biosciences MBX Stock Holding History

Schroder Investment Management Group’s Portfolio MBX Stock Details MBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.54M Sell
57,322
-16,414
-22% -$558K ﹤0.01% 973
2025
Q4 		$2.28M Sell
73,736
-10,030
-12% -$243K ﹤0.01% 870
2025
Q3 		$1.5M Buy
+83,766
New +$1.12M ﹤0.01% 975

Other funds holding MBX

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
NA
NVP Associates Menlo Park, California $176M AUM 208.78% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

Schroder Investment Management Group's MBX Position: Q1 2026 in Review

Schroder Investment Management Group reduced its MBX Biosciences (MBX) stake by 22% in Q1 2026, selling an estimated $558K and leaving 57,322 shares worth $1.54M. The position accounts for ﹤0.01% of the portfolio, ranked #973.

Schroder Investment Management Group first reported a position in MBX in Q3 2025 and has held it in 3 quarters since. The position peaked at $2.28M in Q4 2025. 157 funds tracked by Wall St. Rank hold MBX as of Q1 2026.

  • Schroder Investment Management Group held 57,322 shares of MBX Biosciences worth $1.54M as of Q1 2026.
  • Schroder Investment Management Group sold 16,414 MBX Biosciences shares in Q1 2026, an estimated $558K.
  • MBX Biosciences made up ﹤0.01% of Schroder Investment Management Group's portfolio in Q1 2026, its #973 holding.
  • Schroder Investment Management Group first reported a position in MBX Biosciences in Q3 2025 and has held it in 3 quarters since.
  • Schroder Investment Management Group's MBX Biosciences position peaked at $2.28M in Q4 2025.
  • 157 funds tracked by Wall St. Rank held MBX Biosciences as of Q1 2026.

Based on Schroder Investment Management Group's 13F filing for Q1 2026, filed 14 May 2026.